Exclusion criteria
gastrointestinal diseases, drug addiction, alcoholism, cirrhosis, hernia, angina pectoris, hypoglycemic, allergies, blood sugar reduction, depression, schizophrenia, hypersensitivity, diabetes
ADVERSE REACTIONS, CHRONIC HEPATITIS C, GASTROINTESTINAL DISEASES, UNCONTROLLED HYPERTENSION, CARDIOVASCULAR DISEASE, LIVER CANCER, DISEASES, CIRRHOSIS, THYROID DYSFUNCTION, ALLERGIES, HEART FAILURE, CHRONIC HEPATITIS, HYPERSENSITIVITY, CHRONIC LIVER DISEASE, DIABETES

Participants who experienced adverse reactions such as allergies when taking medicines, health functional foods, etc.Participants with hypersensitivity to mushrooms or a history of the same reaction.Participants with gastrointestinal diseases that may affect the absorption of the test product for human application (e. g., Crohn's disease) or a person with a history of gastrointestinal surgery (except for simple appendectomy or hernia surgery).Participants who show the following results in a diagnostic medical examination.AST, ALT > 2 times the upper limit of the normal range.Other significant diagnostic medical examination findings.Those who have the following clinically significant diseases; diabetes patients taking hypoglycemic drugs or insulin, patients with uncontrolled hypertension (over 140/90 mmHg), patients with blood LDL-cholesterol over 160 mg/dL, patients with thyroid dysfunction, depression, schizophrenia, alcoholism, drug addiction, heart failure, angina pectoris, cardiovascular disease, or acute and chronic liver disease (chronic hepatitis B, chronic hepatitis C, various cirrhosis, liver cancer, etc.).Participants who have taken anti-obesity, anti-depressants, contraceptives, oral steroids, or female hormones. Participants who have taken merchant hormones, or who have taken drugs that affect the absorption, metabolism, and excretion of the test food, or drugs that may affect blood sugar reduction.Pregnant women and lactating women.Those who participated in other clinical trial within 1 month before the first intake date.Participants who cannot follow the requirements of clinical trial by investigator. Participants who proved to be inappropriate by other doctors.